Crossmark

In vivo and in vitro investigations of schisandrin B against angiotensin II induced ferroptosis and atrial fibrosis by regulation of the SIRT1 pathway

Crossref DOI link: https://doi.org/10.1038/s41598-025-89895-0

Published Online: 2025-02-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shi, Mengqing

Ning, Zhongping
Funding

Funding for this research was provided by:

Key Discipline Group of Discipline Construction Plan of Pudong New Area Health Commission (PWZxq2022-11)

Pudong New Area Health Commission Clinical Peak Discipline Construction Plan (PWYgf2021-04)
License Information

Text and Data Mining valid from 2025-02-20

Version of Record valid from 2025-02-20
More Information

Article History

Received: 21 November 2024

Accepted: 10 February 2025

First Online: 20 February 2025

Declarations

:

: This study was approved (2023-C-039-E01) by Shanghai University of Medicine and Health Science Affiliated Zhoupu Hospital Ethics Committee. The authors envisaged all standard protocols in accordance with the 1964 Declaration of Helsinki. All methods carried out in this study were in accordance with ARRIVE guidelines..

: The authors declare no competing interests.

Document is current

Any future updates will be listed below